Vaccine Student Network
Vaccine Chronicles: Experiences from Vaccine Student Research Network Seminar
On 15 January Imperial's Vaccine Student Research Network hosted its first Vaccine Bioscience seminar.
Stories tagged with 'vaccines'
T CELL RESPONSES
T cells may provide more durable protection against Omicron than antibodies
New review suggests T cells are more robust against ‘Omicron breakthroughs’ than antibodies, offering fresh insights for COVID-19 vaccine development.
Cancer therapy
First UK patients receive experimental mRNA therapy for cancer
Cancer patients in the UK are receiving a new therapeutic to help their bodies recognise and fight cancer cells as part of a global trial.
COVID antibody boost
Immunosuppressing medicine can be interrupted to boost COVID-19 vaccine response
Interrupting treatment of immunosuppressing medicines for two weeks can significantly improve antibody immunity provided by COVID-19 booster vaccines.
Future vaccines
£17m awarded to develop globally important vaccine hubs
Imperial researchers will lead two hubs to improve global access to life-saving vaccines.
1
Vaccine Boost
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
COVID-19 ANTIBODIES
Study identifies vulnerable groups least likely to have COVID-19 antibodies
Findings from the MELODY study have identified which people with compromised immune systems are less likely to have COVID-19 antibodies.
drug delivery centre
New centre established to help develop drug delivery and vaccine technologies
The Intracellular Drug Delivery Centre aims to develop new drug delivery technologies and support promising RNA vaccines and therapeutics.
Health insights
MSD partners with Imperial to access insights for better health
Pharmaceutical company MSD has partnered with Imperial to reveal insights that will aid its mission to support clinicians and save and improve lives.
Vaccine Policy
Delaying second doses of vaccine reduced COVID-19 hospitalisations and deaths
Delaying people’s second COVID-19 vaccine dose likely prevented tens of thousands of hospitalisations and thousands of deaths in England.
